Antiretroviral Therapy for Acute HIV Infection (AAHIV)
This study is currently recruiting participants.
Verified January 2017 by Assoc.Prof.Jintanat Ananworanich, M.D., South East Asia Research Collaboration with Hawaii
South East Asia Research Collaboration with Hawaii
Thai Red Cross AIDS Research Centre
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Assoc.Prof.Jintanat Ananworanich, M.D., South East Asia Research Collaboration with Hawaii
First received: November 21, 2008
Last updated: January 25, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||July 2021|
|Estimated Primary Completion Date:||April 2021 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
de Souza MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, Fletcher JL, Chomchey N, Kroon ED, Ubolyam S, Michael NL, Robb ML, Phanuphak P, Kim JH, Phanuphak N, Ananworanich J; RV254/SEARCH010 Study Group. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology. Clin Infect Dis. 2016 Aug 15;63(4):555-61. doi: 10.1093/cid/ciw365. Epub 2016 Jun 17.